Wang Ying, Xu Yanli, Perepelov Andrei V, Qi Yuanyuan, Knirel Yuriy A, Wang Lei, Feng Lu
TEDA School of Biological Sciences and Biotechnology, Nankai University, 23 Hongda Street, TEDA, Tianjin 300457, People's Republic of China.
J Bacteriol. 2007 Dec;189(23):8626-35. doi: 10.1128/JB.00777-07. Epub 2007 Sep 28.
O-antigen variation due to the presence of different types of sugars and sugar linkages is important for the survival of bacteria threatened by host immune systems. The O antigens of Shigella dysenteriae type 7 and Escherichia coli O7 contain 4-(N-acetylglycyl)amino-4,6-dideoxy-d-glucose (d-Qui4NGlyAc) and 4-acetamido-4,6-dideoxy-d-glucose (d-Qui4NAc), respectively, which are sugars not often found in studied polysaccharides. In this study, we characterized the biosynthetic pathways for dTDP-d-Qui4N and dTDP-d-Qui4NAc (the nucleotide-activated precursors of d-Qui4NGlyAc and d-Qui4NAc in O antigens). Predicted genes involved in the synthesis of the two sugars were cloned, and the gene products were overexpressed and purified as His-tagged fusion proteins. In vitro enzymatic reactions were carried out using the purified proteins, and the reaction products were analyzed by capillary electrophoresis, electrospray ionization-mass spectrometry, and nuclear magnetic resonance spectroscopy. It is shown that in S. dysenteriae type 7 and E. coli O7, dTDP-d-Qui4N is synthesized from alpha-d-glucose-1-phosphate in three reaction steps catalyzed by glucose-1-phosphate thymidyltransferase (RmlA), dTDP-d-glucose 4,6-dehydratase (RmlB), and dTDP-4-keto-6-deoxy-d-glucose aminotransferase (VioA). An additional acetyltransferase (VioB) catalyzes the conversion of dTDP-d-Qui4N into dTDP-d-Qui4NAc in E. coli O7. Kinetic parameters and some other properties of VioA and VioB are described and differences between VioA proteins from S. dysenteriae type 7 (VioA(D7)) and E. coli O7 (VioA(O7)) discussed. To our knowledge, this is the first time that functions of VioA and VioB have been biochemically characterized. This study provides valuable enzyme sources for the production of dTDP-d-Qui4N and dTDP-d-Qui4NAc, which are potentially useful in the pharmaceutical industry for drug development.
由于存在不同类型的糖类和糖键,O抗原变异对于受到宿主免疫系统威胁的细菌生存至关重要。7型痢疾志贺菌和大肠杆菌O7的O抗原分别含有4-(N-乙酰甘氨酰)氨基-4,6-二脱氧-D-葡萄糖(d-Qui4NGlyAc)和4-乙酰氨基-4,6-二脱氧-D-葡萄糖(d-Qui4NAc),这些糖类在已研究的多糖中并不常见。在本研究中,我们对dTDP-d-Qui4N和dTDP-d-Qui4NAc(O抗原中d-Qui4NGlyAc和d-Qui4NAc的核苷酸活化前体)的生物合成途径进行了表征。克隆了预测参与这两种糖类合成的基因,并将基因产物作为His标签融合蛋白进行过表达和纯化。使用纯化的蛋白进行体外酶促反应,并通过毛细管电泳、电喷雾电离质谱和核磁共振光谱对反应产物进行分析。结果表明,在7型痢疾志贺菌和大肠杆菌O7中,dTDP-d-Qui4N由α-D-葡萄糖-1-磷酸在由葡萄糖-1-磷酸胸苷酰转移酶(RmlA)、dTDP-D-葡萄糖4,6-脱水酶(RmlB)和dTDP-4-酮-6-脱氧-D-葡萄糖氨基转移酶(VioA)催化的三个反应步骤中合成。在大肠杆菌O7中,一种额外的乙酰转移酶(VioB)催化dTDP-d-Qui4N转化为dTDP-d-Qui4NAc。描述了VioA和VioB的动力学参数及其他一些特性,并讨论了7型痢疾志贺菌(VioA(D7))和大肠杆菌O7(VioA(O7))的VioA蛋白之间的差异。据我们所知,这是首次对VioA和VioB的功能进行生化表征。本研究为生产dTDP-d-Qui4N和dTDP-d-Qui4NAc提供了有价值的酶源,它们在制药行业用于药物开发可能具有潜在用途。